PMCB icon

PharmaCyte Biotech

32 hedge funds and large institutions have $2.35M invested in PharmaCyte Biotech in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$18K
Puts
$13K
Net Calls
Net Calls Change

Top Buyers

1 +$99.2K
2 +$47.6K
3 +$32.1K
4
Renaissance Technologies
Renaissance Technologies
New York
+$11.2K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.21K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$655K
2
$466K
3
$370K
4
$179K
5
$178K
6
$82K
7
$63.3K
8
$62.1K
9
$61.8K
10
$50.1K
11
$47.6K
12
$41.7K
13
$35.9K
14
$32.1K
15
$10K
16
$4.05K
17
$3.8K
18
$2K
19
$1.73K
20
$505
21
$135
22
$119
23
$91
24
$31
25
$30